1,535
Participants
Start Date
February 28, 2001
Primary Completion Date
August 31, 2003
Study Completion Date
July 31, 2014
5-FU, epirubicin and cyclophosphamide
Tailored dose escalation of epirubicin and cyclophosphamide.
Collaborators (1)
Scandinavian Breast Group
OTHER
Danish Breast Cancer Cooperative Group
OTHER
Swedish Cancer Society
OTHER
Swedish Cancer Foundation
OTHER
Pharmacia Pharmaceutical Company
UNKNOWN
Swedish Breast Cancer Group
OTHER
Henrik Lindman
OTHER